# Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/polatuzumab-vedotin-in-relapsed-or-refractory-diffuse-large-b-cell-lymphoma/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Laurie H. Sehn,Alex F. Herrera,Christopher R. Flowers,Manali Kamdar,Andrew McMillan,Mark Hertzberg,Sarit Assouline,Tae Min Kim,Won Seog Kim,Muhıt Özcan,Jamie Hirata,Elicia Penuel,Joseph N. Paulson,Ji Cheng,Grace Ku,Matthew J. Matasar |
| Citations | 780 |
| DOI | 10.1200/jco.19.00172 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1200/jco.19.00172 |
| OpenAlex ID | https://openalex.org/W2984927918 |
| PMID | 31693429 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Tae Min Kim](https://scholariq.org/researchers/tae-min-kim/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

## Paper topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cutaneous lymphoproliferative disorders research](https://scholariq.org/topics/cutaneous-lymphoproliferative-disorders-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.